Arrowhead Pharmaceuticals, Inc. (ARWR)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS04280A1007
47.13 USD
-0.04% today Updated 13 Nov 2026 16:28
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Arrowhead Pharmaceuticals, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:28. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
—No date announced yet
Last results
-1.52 vs -1.50 estimated
12 Nov 2026 · Miss -1.2%
Beat the estimate
3 of 12
9 missed · 0 in line
Average surprise
+6.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Nov 2026 16:00 | -1.50 | -1.52 | -1.2% | Miss |
| 04 Aug 2026 16:00 | -1.23 | -1.36 | -10.4% | Miss |
| 07 May 2026 16:00 | -1.11 | -0.93 | +16.0% | Beat |
| 05 Feb 2026 16:00 | -0.37 | 0.22 | +159.9% | Beat |
| 25 Nov 2025 16:00 | -0.16 | -0.18 | -14.5% | Miss |
| 07 Aug 2025 16:00 | -1.10 | -1.26 | -14.4% | Miss |
| 12 May 2025 16:00 | -0.46 | 2.75 | +695.0% | Beat |
| 10 Feb 2025 16:00 | -0.72 | -1.39 | -92.2% | Miss |
| 26 Nov 2024 16:00 | -0.92 | -1.37 | -48.6% | Miss |
| 08 Aug 2024 16:00 | -0.59 | -1.38 | -134.5% | Miss |
| 09 May 2024 16:00 | -0.20 | -1.02 | -422.8% | Miss |
| 06 Feb 2024 16:00 | -0.83 | -1.24 | -50.3% | Miss |
| 29 Nov 2023 16:00 | -0.58 | -1.02 | -76.4% | Miss |
| 07 Aug 2023 16:00 | -0.53 | -0.96 | -81.8% | Miss |
| 02 May 2023 16:00 | -0.59 | 0.45 | +176.5% | Beat |
| 06 Feb 2023 16:00 | 0.13 | -0.39 | -389.1% | Miss |
| 28 Nov 2022 16:00 | -0.54 | -0.81 | -48.8% | Miss |
| 04 Aug 2022 16:00 | -0.51 | -0.68 | -33.7% | Miss |
| 10 May 2022 16:00 | 0.18 | 0.41 | +124.2% | Beat |
| 02 Feb 2022 16:00 | -0.58 | -0.60 | -3.3% | Miss |
| 22 Nov 2021 16:00 | -0.35 | -0.61 | -73.1% | Miss |
| 05 Aug 2021 16:00 | -0.14 | -0.29 | -108.3% | Miss |
| 04 May 2021 16:00 | -0.17 | -0.26 | -51.3% | Miss |
| 04 Feb 2021 16:00 | -0.24 | -0.20 | +17.6% | Beat |
| 23 Nov 2020 16:00 | -0.21 | -0.48 | -134.1% | Miss |
| 05 Aug 2020 16:00 | -0.20 | -0.13 | +36.6% | Beat |
| 07 May 2020 16:00 | -0.11 | -0.20 | -85.2% | Miss |
| 05 Feb 2020 16:00 | -0.07 | -0.03 | +55.0% | Beat |
| 25 Nov 2019 16:00 | 0.17 | 0.11 | -34.0% | Miss |
| 05 Aug 2019 16:00 | 0.12 | 0.21 | +75.0% | Beat |
| 08 May 2019 16:00 | 0.20 | 0.24 | +21.2% | Beat |
| 07 Feb 2019 16:00 | 0.69 | 0.13 | -81.3% | Miss |
| 11 Dec 2018 16:00 | -0.17 | -0.12 | +30.8% | Beat |
| 07 Aug 2018 16:00 | -0.19 | -0.18 | +4.4% | Beat |
| 08 May 2018 16:00 | -0.18 | -0.18 | +2.7% | Beat |
| 09 Feb 2018 16:00 | -0.16 | -0.18 | -10.8% | Miss |
| 12 Dec 2017 16:00 | -0.12 | -0.14 | -16.7% | Miss |
| 03 Aug 2017 16:00 | -0.12 | -0.07 | +43.6% | Beat |
| 03 May 2017 16:00 | -0.18 | -0.08 | +54.6% | Beat |
| 06 Feb 2017 16:00 | -0.21 | -0.17 | +19.1% | Beat |
| 14 Dec 2016 16:00 | -0.31 | -0.30 | +2.2% | Beat |
| 09 Aug 2016 16:00 | -0.36 | -0.32 | +11.7% | Beat |
| 10 May 2016 16:00 | -0.36 | -0.35 | +3.5% | Beat |
| 09 Feb 2016 16:00 | -0.38 | -0.32 | +15.8% | Beat |
| 14 Dec 2015 16:00 | -0.39 | -0.42 | -7.9% | Miss |
| 04 Aug 2015 16:00 | -0.39 | -0.27 | +30.8% | Beat |
| 11 May 2015 16:00 | -0.36 | -0.33 | +6.9% | Beat |
| 09 Feb 2015 16:00 | -0.32 | -0.41 | -28.1% | Miss |
| 25 Nov 2014 16:00 | -0.25 | -0.34 | -38.1% | Miss |
| 12 Aug 2014 16:00 | -0.22 | -0.22 | +0.4% | In line |
| 06 May 2014 16:00 | -0.20 | -0.31 | -55.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 829.4M | +23,258.2% | -1.6M | -0.2% | -0.01 | +99.8% | 156.9M |
| 2024 | 3.6M | -98.5% | -599.5M | -16,882.4% | -5.00 | -160.4% | -604.3M |
| 2023 | 240.7M | -1.0% | -205.3M | -85.3% | -1.92 | -15.0% | -330.6M |
| 2022 | 243.2M | — | -176.1M | -72.4% | -1.67 | — | -188.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 60.55 | 62.00 | 44.52 | 47.13 | -21.32% | 23,944,643 | |
| Oct 2026 | 65.00 | 66.16 | 55.83 | 59.90 | -8.48% | 38,115,500 | |
| Sep 2026 | 81.14 | 87.20 | 63.99 | 65.45 | -20.56% | 48,075,300 | |
| Aug 2026 | 84.82 | 90.97 | 80.75 | 82.39 | -2.67% | 23,875,600 | |
| Jul 2026 | 82.28 | 95.49 | 69.88 | 84.65 | +3.85% | 50,714,100 | |
| Jun 2026 | 76.94 | 84.55 | 69.30 | 81.51 | +4.62% | 54,507,300 | |
| May 2026 | 74.56 | 82.26 | 69.88 | 77.91 | +6.03% | 34,110,900 | |
| Apr 2026 | 63.35 | 76.48 | 59.25 | 73.48 | +17.19% | 37,192,400 | |
| Mar 2026 | 61.50 | 67.15 | 54.02 | 62.70 | -0.90% | 56,396,500 | |
| Feb 2026 | 68.51 | 76.11 | 60.34 | 63.27 | -8.74% | 69,289,600 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Arrowhead Pharmaceuticals (NASDAQ:ARWR) Rallies as REDEMPLO Launch and Plozasiran Fast Review Offset Earnings Miss (opens in a new tab) ChartMill · 12 Nov 2026 23:02
- Arrowhead Pharmaceuticals falls on earnings miss (opens in a new tab) Investing.com · 12 Nov 2026 22:03
- Arrowhead Research: Fiscal Q4 Earnings Snapshot (opens in a new tab) Associated Press · 12 Nov 2026 21:22
- Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results (opens in a new tab) 12 Nov 2026 21:01
- Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at AHA Scientific Sessions 2026 - Slideshow (opens in a new tab) SeekingAlpha · 11 Nov 2026 18:16
- Is Arrowhead Pharmaceuticals (ARWR) Worth Its Price After UK Approval? (opens in a new tab) Simply Wall St. · 10 Nov 2026 03:11
- Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conferences (opens in a new tab) 09 Nov 2026 21:00
- Reported Saturday, Arrowhead Presents Plozasiran Data At AHA 2026 Showing 78% Lower Acute Pancreatitis Event Rate Versus Placebo And Sustained Triglyceride Reductions, Plus ARO-DIMER-PA Lowering LDL Cholesterol And Triglycerides (opens in a new tab) Benzinga · 09 Nov 2026 04:23
- Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates (opens in a new tab) 07 Nov 2026 21:15
- Arrowhead Pharmaceuticals Refinances Existing Credit Facility, Lowering Borrowing Costs and Extending Maturity (opens in a new tab) 04 Nov 2026 12:30
- Arrowhead Refinances Debt, Cuts Borrowing Costs And Boosts Financial Flexibility With New $400M Sixth Street Loan (opens in a new tab) Benzinga · 04 Nov 2026 08:32
- Arrowhead Pharmaceuticals to Webcast 2026 Fiscal Year-End Results (opens in a new tab) 03 Nov 2026 21:00
- Arrowhead Pharmaceuticals to Present Important Clinical Data at the American Heart Association Scientific Sessions 2026 (opens in a new tab) 02 Nov 2026 12:30
- Arrowhead Pharma To Present Three-Year Data From PALISADE Study And Open-Label Extension At American Heart Association Scientific Sessions 2026 (opens in a new tab) Benzinga · 02 Nov 2026 08:32
- Arrowhead gains UK marketing authorisation for Redemplo (opens in a new tab) Pharmaceutical Technology · 28 Oct 2026 10:50
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 47.15 USD
- Market cap
- 6.6B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ARWR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.